Bellamkonda Kirthi S, Fereydooni Arash, Trott Kiley, Lee Yan, Mehra Saral, Nassiri Naiem
Division of Vascular Surgery and Endovascular Therapy, Yale School of Medicine, New Haven, Conn.
Division of Otolaryngology, Yale School of Medicine, New Haven, Conn.
J Vasc Surg Cases Innov Tech. 2021 Feb 9;7(2):230-234. doi: 10.1016/j.jvscit.2021.01.005. eCollection 2021 Jun.
Arteriovenous malformations (AVMs) classically feature an intervening nidus of poorly differentiated endothelium. The pillar of modern AVM treatment is intranidal delivery and deposition of various liquid embolic agents such as n-butyl cyanoacrylate, ethylene vinyl alcohol copolymer, and ethanol. These agents are cumbersome to prepare, deliver, and deploy and have been associated with complications related to limited delivery control, nonretrievability, frequent microcatheter exchanges, and nontarget embolization. Coils and other proximal occlusive agents have not been traditionally recommended as sole embolic agents for AVM treatment given the inherent lack of adequate AVM nidus penetration with previous coil technologies. In the present report, we have described a series of three patients with AVMs in whom newer generation, platinum-based, packing coils were used safely and effectively as the primary agent for superselective nidal penetration and embolization.
动静脉畸形(AVM)的典型特征是存在一个由分化不良的内皮细胞构成的中间病灶。现代AVM治疗的支柱是在病灶内注入和沉积各种液体栓塞剂,如氰基丙烯酸正丁酯、乙烯-乙烯醇共聚物和乙醇。这些栓塞剂在制备、输送和部署方面都很麻烦,并且与因输送控制有限、不可回收、频繁更换微导管以及非靶栓塞相关的并发症有关。由于以往的线圈技术固有地缺乏对AVM病灶的充分穿透能力,传统上不推荐使用线圈和其他近端闭塞剂作为AVM治疗的唯一栓塞剂。在本报告中,我们描述了一系列3例AVM患者,其中新一代的铂基填充线圈被安全有效地用作超选择性病灶穿透和栓塞的主要药物。